Abstract
Biosimilars are biologic products that are highly similar, but not identical, to a licensed reference (or “originator”) biologic product. These agents have the potential to provide efficiencies and improve access to treatment f...
Abstract
Cancer care delivery research (CCDR) is an emerging field that investigates ways to optimally provide care for patients within complex health-care systems. Novel research designs are essential to efficiently study CCDR research...
Abstract
This article reviews cognitive behavioral therapy techniques for sleep in the cancer realm. There are unique factors associated with cancer that can exacerbate sleep issues. Stimulus control, sleep restriction, relaxation, para...
Abstract
Trametinib is a MEK inhibitor approved both as a single agent and in combination with dabrafenib for the treatment of BRAF V600E or V600K mutated melanoma. It is a once-daily oral medication that was approved based on progressi...
Abstract
The treatment of breast cancer has been revolutionized by the development of HER2-targeted treatments for patients who are HER2 positive. The HER2 protein is present at high levels in about 30% of breast cancer patients. These ...
Abstract
The Association of Community Cancer Centers (ACCC), Hematology/Oncology Pharmacy Association (HOPA), National Community Oncology Dispensing Association (NCODA), and Oncology Nursing Society (ONS) partnered together to create a ...
Abstracts from JADPRO Live 2018
THE DIPLOMAT HOTEL, HOLLYWOOD, FLORIDA • NOVEMBER 1–4, 2018
The posters for the abstracts below can be found at eventscribe.com/2018/posters/JADPROLIVE/home.asp.
